International audienceWe describe here a simple model for the interaction between leukemic cells and the autologous immune response in chronic phase chronic myelogenous leukemia (CML). This model is a simplified version of the model we proposed in [Clapp et al., Cancer Research, 75:4053-4062, 2015]. Our simplification is based on the observation that certain key characteristics of the dynamics of CML can be captured with a three compartments model: two for the leukemic cells (stem cells and mature cells) and one for the immune response. We characterize the existence of steady states and their stability for generic forms of immunosuppres-sive effects of leukemic cells. We provide a complete co-dimension one bifurcation analysis. Our results ...
International audienceWe propose and analyze a simplified version of a partial differential equation...
Imatinib and other tyrosine kinase inhibitors (TKI) have improved treatment of chronic myelogenous l...
Chronic myeloid leukemia (CML) is a blood cancer characterized by dysregulated production of maturin...
International audienceWe describe here a simple model for the interaction between leukemic cells and...
We propose and analyze a system of partial differential equations (PDEs) for chronic myeloid leukemi...
We describe a deterministic and a stochastic model to understand the dynamics of chronic myelogenous...
Background. Recent mathematical models have been developed to study the dynamics of chronic myelogen...
Chronic Myelogenous Leukemia (CML) is one of the most common types of leukemia. It is characterized ...
This thesis deals with the dynamics of models of chronic myeloid leukemia (CML). Models of interest ...
The basic model. Our mathematical model is based on the architecture of the hematopoi-etic system as...
Background The introduction of imatinib, the first of a family of abl kinase inhibitors, opened a ne...
Recent clinical findings in chronic myeloid leukemia (CML) patients suggest that the risk of molecul...
The evolutionary dynamics of cancerous cell populations in a model of Chronic Myeloid Leukemia (CML)...
In this paper, a mathematical analysis of a model describing the evolution of chronic myeloid leukem...
Cette thèse porte sur la dynamique de modèles de leucémie myéloïde chronique (LMC). Les modèles qui ...
International audienceWe propose and analyze a simplified version of a partial differential equation...
Imatinib and other tyrosine kinase inhibitors (TKI) have improved treatment of chronic myelogenous l...
Chronic myeloid leukemia (CML) is a blood cancer characterized by dysregulated production of maturin...
International audienceWe describe here a simple model for the interaction between leukemic cells and...
We propose and analyze a system of partial differential equations (PDEs) for chronic myeloid leukemi...
We describe a deterministic and a stochastic model to understand the dynamics of chronic myelogenous...
Background. Recent mathematical models have been developed to study the dynamics of chronic myelogen...
Chronic Myelogenous Leukemia (CML) is one of the most common types of leukemia. It is characterized ...
This thesis deals with the dynamics of models of chronic myeloid leukemia (CML). Models of interest ...
The basic model. Our mathematical model is based on the architecture of the hematopoi-etic system as...
Background The introduction of imatinib, the first of a family of abl kinase inhibitors, opened a ne...
Recent clinical findings in chronic myeloid leukemia (CML) patients suggest that the risk of molecul...
The evolutionary dynamics of cancerous cell populations in a model of Chronic Myeloid Leukemia (CML)...
In this paper, a mathematical analysis of a model describing the evolution of chronic myeloid leukem...
Cette thèse porte sur la dynamique de modèles de leucémie myéloïde chronique (LMC). Les modèles qui ...
International audienceWe propose and analyze a simplified version of a partial differential equation...
Imatinib and other tyrosine kinase inhibitors (TKI) have improved treatment of chronic myelogenous l...
Chronic myeloid leukemia (CML) is a blood cancer characterized by dysregulated production of maturin...